Suppr超能文献

在大流行背景下诊断新型冠状病毒肺炎:肺部超声与计算机断层扫描(LUVCT)——一项多中心、前瞻性、观察性研究。

Diagnosing COVID-19 pneumonia in a pandemic setting: Lung Ultrasound CT (LUVCT) - a multicentre, prospective, observational study.

作者信息

Lieveld Arthur W E, Kok Bram, Schuit Frederik H, Azijli Kaoutar, Heijmans Jarom, van Laarhoven Arjan, Assman Natascha L, Kootte Ruud S, Olgers Tycho J, Nanayakkara Prabath W B, Bosch Frank H

机构信息

Section General and Acute Internal Medicine, Dept of Internal Medicine, Amsterdam Public Health Research Institute, Amsterdam UMC, location VUmc, Amsterdam, The Netherlands.

These authors contributed equally.

出版信息

ERJ Open Res. 2020 Dec 21;6(4). doi: 10.1183/23120541.00539-2020. eCollection 2020 Oct.

Abstract

BACKGROUND

In this coronavirus disease 2019 (COVID-19) pandemic, fast and accurate testing is needed to profile patients at the emergency department (ED) and efficiently allocate resources. Chest imaging has been considered in COVID-19 workup, but evidence on lung ultrasound (LUS) is sparse. We therefore aimed to assess and compare the diagnostic accuracy of LUS and computed tomography (CT) in suspected COVID-19 patients.

METHODS

This multicentre, prospective, observational study included adult patients with suspected COVID-19 referred to internal medicine at the ED. We calculated diagnostic accuracy measures for LUS and CT using both PCR and multidisciplinary team (MDT) diagnosis as reference. We also assessed agreement between LUS and CT, and between sonographers.

RESULTS

One hundred and eighty-seven patients were recruited between March 19 and May 4, 2020. Area under the receiver operating characteristic (AUROC) was 0.81 (95% CI 0.75-0.88) for LUS and 0.89 (95% CI 0.84-0.94) for CT. Sensitivity and specificity for LUS were 91.9% (95% CI 84.0-96.7) and 71.0% (95% CI 61.1-79.6), respectively, 88.4% (95% CI 79.7-94.3) and 82.0% (95% CI 73.1-89.0) for CT. Negative likelihood ratio was 0.1 (95% CI 0.06-0.24) for LUS and 0.14 (95% CI 0.08-0.3) for CT. No patient with a false negative LUS required supplemental oxygen or admission. LUS specificity increased to 80% (95% CI 69.9-87.9) compared to MDT diagnosis, with an AUROC of 0.85 (95% CI 0.79-0.91). Agreement between LUS and CT was 0.65. Interobserver agreement for LUS was good: 0.89 (95% CI 0.83-0.93).

CONCLUSION

LUS and CT have comparable diagnostic accuracy for COVID-19 pneumonia. LUS can safely exclude clinically relevant COVID-19 pneumonia and may aid COVID-19 diagnosis in high prevalence situations.

摘要

背景

在2019冠状病毒病(COVID-19)大流行期间,需要快速准确的检测来对急诊科(ED)的患者进行评估,并有效分配资源。胸部成像已被纳入COVID-19的检查流程,但关于肺部超声(LUS)的证据较少。因此,我们旨在评估和比较LUS与计算机断层扫描(CT)在疑似COVID-19患者中的诊断准确性。

方法

这项多中心、前瞻性、观察性研究纳入了在急诊科内科就诊的疑似COVID-19成年患者。我们以聚合酶链反应(PCR)和多学科团队(MDT)诊断作为参考,计算LUS和CT的诊断准确性指标。我们还评估了LUS与CT之间以及超声检查人员之间的一致性。

结果

2020年3月19日至5月4日期间招募了187例患者。LUS的受试者操作特征曲线下面积(AUROC)为0.81(95%可信区间0.75-0.88),CT为0.89(95%可信区间0.84-0.94)。LUS的敏感性和特异性分别为91.9%(95%可信区间84.0-96.7)和71.0%(95%可信区间61.1-79.6),CT分别为88.4%(95%可信区间79.7-94.3)和82.0%(95%可信区间73.1-89.0)。LUS的阴性似然比为0.1(95%可信区间0.06-0.24),CT为0.14(95%可信区间0.08-0.3)。LUS检查结果为假阴性的患者均无需补充氧气或住院治疗。与MDT诊断相比,LUS的特异性提高到80%(95%可信区间69.9-87.9),AUROC为0.85(95%可信区间0.79-0.91)。LUS与CT之间的一致性为0.65。LUS的观察者间一致性良好:0.89(95%可信区间0.83-0.93)。

结论

LUS和CT对COVID-19肺炎具有相当的诊断准确性。LUS可以安全地排除具有临床意义的COVID-19肺炎,并且在高流行情况下可能有助于COVID-19的诊断。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d13/7792856/bcadf16c1f75/00539-2020.01.jpg

相似文献

1
Diagnosing COVID-19 pneumonia in a pandemic setting: Lung Ultrasound CT (LUVCT) - a multicentre, prospective, observational study.
ERJ Open Res. 2020 Dec 21;6(4). doi: 10.1183/23120541.00539-2020. eCollection 2020 Oct.
2
Is Lung Ultrasound Imaging a Worthwhile Procedure for Severe Acute Respiratory Syndrome Coronavirus 2 Pneumonia Detection?
J Ultrasound Med. 2021 Jun;40(6):1113-1123. doi: 10.1002/jum.15487. Epub 2020 Sep 7.
3
Comparative study of lung ultrasound and chest computed tomography scan in the assessment of severity of confirmed COVID-19 pneumonia.
Intensive Care Med. 2020 Sep;46(9):1707-1713. doi: 10.1007/s00134-020-06186-0. Epub 2020 Jul 29.
4
Lung ultrasound in ruling out COVID-19 pneumonia in the ED: a multicentre prospective sensitivity study.
Emerg Med J. 2022 Mar;39(3):199-205. doi: 10.1136/emermed-2020-210973. Epub 2021 Dec 22.
9
Assessing COVID-19 pneumonia-Clinical extension and risk with point-of-care ultrasound: A multicenter, prospective, observational study.
J Am Coll Emerg Physicians Open. 2021 May 1;2(3):e12429. doi: 10.1002/emp2.12429. eCollection 2021 Jun.
10
Lung Ultrasound in COVID-19 Pneumonia: Correlations with Chest CT on Hospital admission.
Respiration. 2020;99(7):617-624. doi: 10.1159/000509223. Epub 2020 Jun 22.

引用本文的文献

1
Pulmonary ultrasound in COVID-19 and non-COVID-19 pneumonia in South Africa: An observational study.
Afr J Thorac Crit Care Med. 2025 Mar 28;31(1):e1887. doi: 10.7196/AJTCCM.2025.v31i1.1887. eCollection 2025.
2
Lung Ultrasound and High-Resolution Computed Tomography in Suspected COVID-19 Patients Admitted to the Emergency Department: A Comparison.
J Diagn Med Sonogr. 2023 Jan 29;39(4):332-346. doi: 10.1177/87564793221147496. eCollection 2023 Jul-Aug.
4
Correlation between Serum Biomarkers and Lung Ultrasound in COVID-19: An Observational Study.
Diagnostics (Basel). 2024 Feb 14;14(4):421. doi: 10.3390/diagnostics14040421.
5
Point-of-care ultrasound use in COVID-19: a narrative review.
Ann Transl Med. 2024 Feb 1;12(1):13. doi: 10.21037/atm-23-1403. Epub 2023 Jul 13.
6
Handheld Lung Ultrasound to Detect COVID-19 Pneumonia in Inpatients: A Prospective Cohort Study.
POCUS J. 2023 Nov 27;8(2):175-183. doi: 10.24908/pocus.v8i2.16484. eCollection 2023.
7
Serial lung ultrasound in monitoring viral pneumonia: the lesson learned from COVID-19.
ERJ Open Res. 2023 Aug 14;9(4). doi: 10.1183/23120541.00017-2023. eCollection 2023 Jul.
9
Lung ultrasound must be the first-line image technique in COVID-19 patients.
Eur J Intern Med. 2023 Apr;110:21-22. doi: 10.1016/j.ejim.2023.02.018. Epub 2023 Feb 20.

本文引用的文献

2
Access to lifesaving medical resources for African countries: COVID-19 testing and response, ethics, and politics.
Lancet. 2020 May 30;395(10238):1735-1738. doi: 10.1016/S0140-6736(20)31093-X. Epub 2020 May 7.
3
What's new in lung ultrasound during the COVID-19 pandemic.
Intensive Care Med. 2020 Jul;46(7):1445-1448. doi: 10.1007/s00134-020-06048-9. Epub 2020 May 4.
4
CO-RADS: A Categorical CT Assessment Scheme for Patients Suspected of Having COVID-19-Definition and Evaluation.
Radiology. 2020 Aug;296(2):E97-E104. doi: 10.1148/radiol.2020201473. Epub 2020 Apr 27.
5
Lung ultrasonography in a woman with COVID-19: This examination could be remote.
CMAJ. 2020 Apr 20;192(16):E435. doi: 10.1503/cmaj.75302.
6
The Promise and Peril of Antibody Testing for COVID-19.
JAMA. 2020 May 19;323(19):1881-1883. doi: 10.1001/jama.2020.6170.
7
Thoracic ultrasound and SARS-COVID-19: a pictorial essay.
J Ultrasound. 2020 Jun;23(2):217-221. doi: 10.1007/s40477-020-00458-7. Epub 2020 Apr 16.
8
POCUS in COVID-19: pearls and pitfalls.
Lancet Respir Med. 2020 May;8(5):e34. doi: 10.1016/S2213-2600(20)30166-1. Epub 2020 Apr 8.
9
Point-of-care lung ultrasound in patients with COVID-19 - a narrative review.
Anaesthesia. 2020 Aug;75(8):1096-1104. doi: 10.1111/anae.15082. Epub 2020 Apr 28.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验